Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Pfizer Ltd.
NSE: PFIZER
|
BSE: 500680
|
ISIN: INE182A01018
|
Industry: Pharmaceuticals
Results
|
Mid-range Performer
5140.0000
65.00
(
1.28
%)
NSE
Nov 10, 2025
15:31 PM
38.88% Gain from 52W Low
Volume:
11,870
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Pfizer Ltd.
edited
03 Dec 2020
Results
5140.00
1.28%
Committed to engaging with Indian govt to bring Covid-19 vaccine: Pfizer
Business Standard
The UK on Wednesday became the first country to approve the Pfizer/BioNTech vaccine.
Pfizer Ltd. has gained
20.94%
in the last 6 Months
High-stakes coronavirus vaccine rollout under spotlight amid challenges
Business Standard |
04 Dec 2020
9 more
India Coronavirus Dispatch: Vaccine volunteers say the risk was worth it
Business Standard |
03 Dec 2020
Pfizer-BioNTech Covid vaccine first to get Emergency Use Authorisation from UK
Business Line |
03 Dec 2020
Pfizer shares extend rally, can rise further if sustains Rs 5,100 level
Moneycontrol |
03 Dec 2020
There will be more Covid vaccine doses than needed by 2021 end: Pfizer CEO
Business Standard |
03 Dec 2020
Coronavirus vaccine: Pfizer CEO confident supply will exceed needs by end of 2021
Business Today |
03 Dec 2020
Don't get carried away with Covid-19 vaccine 'over optimism': UK PM Johnson
Business Standard |
03 Dec 2020
Pfizer confident there will be more doses than needs by end of 2021
Moneycontrol |
03 Dec 2020
UK approves Pfizer, becomes the first country to roll out Covid-19 vaccine
Business Standard |
03 Dec 2020
Supply chain challenges led to target cut for Covid vaccine doses: Pfizer
Business Standard |
04 Dec 2020
More from Pfizer Ltd.
Recommended
IPO market heats up: Physicswallah and six others to open, five listings this week
|
10 Nov 2025, 05:36PM
Market closes higher, KPIT Technologies' Q2 revenue beats Forecaster estimates by 3%
Trendlyne Marketwatch |
10 Nov 2025, 03:59PM
Earnings Call Transcript - Pfizer
|
04 Feb 2020